Related references
Note: Only part of the references are listed.Anticonvulsant effects of acetaminophen in mice: Comparison with the effects of nonsteroidal anti-inflammatory drugs
Katsuya Suemaru et al.
EPILEPSY RESEARCH (2018)
Discovery of novel Methylsulfonyl phenyl derivatives as potent human Cyclooxygenase-2 inhibitors with effective anticonvulsant action: Design, synthesis, in-silico, in-vitro and in-vivo evaluation
Chandra Bhushan Mishra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Celecoxib Ameliorates Seizure Susceptibility in Autosomal Dominant Lateral Temporal Epilepsy
Lin Zhou et al.
JOURNAL OF NEUROSCIENCE (2018)
Postictal hypoperfusion/hypoxia provides the foundation for a unified theory of seizure-induced brain abnormalities and behavioral dysfunction
Jordan S. Farrell et al.
EPILEPSIA (2017)
Neuroinflammatory targets and treatments for epilepsy validated in experimental models
Eleonora Aronica et al.
EPILEPSIA (2017)
Cyclooxygenase-2 inhibitors differentially attenuate pentylenetetrazolinduced seizures and increase of pro- and anti-inflammatory cytokine levels in the cerebral cortex and hippocampus of mice
Fernanda Rossatto Temp et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Excitotoxicity-induced prostaglandin D2 production induces sustained microglial activation and delayed neuronal death
Kensuke Iwasa et al.
JOURNAL OF LIPID RESEARCH (2017)
Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs
Wolfgang Loscher
NEUROCHEMICAL RESEARCH (2017)
Mossy Fiber Sprouting in the Epileptic Brain: Taking on the Lernaean Hydra
Steve Danzer
EPILEPSY CURRENTS (2017)
Acute effects of aceclofenac, COX-2 inhibitor, on penicillin-induced epileptiform activity
Mehmet Taskiran et al.
BRAIN RESEARCH BULLETIN (2017)
Aspirin and (or) omega-3 polyunsaturated fatty acids protect against corticohippocampal neurodegeneration and downregulate lipoxin A4 production and formyl peptide receptor-like 1 expression in pentylenetetrazole-kindled rats
Basma A. Abd-Elghafour et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2017)
Apelin-13 protects rat primary cortical glia-neuron co-culture against pentylenetetrazole-induced toxicity
Taj Pari Kalantaripour et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma
Ersoy Oksuz et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Effect of diclofenac sodium on seizures and inflammatory profile induced by kindling seizure model
Vinicius Vieira et al.
EPILEPSY RESEARCH (2016)
Anti-Inflammatory Small Molecules To Treat Seizures anc Eoileosy: From Bench to Becsice
Avijit Dey et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Postictal behavioural impairments are due to a severe prolonged hypoperfusion/ hypoxia event that is COX-2 dependent
Jordan S. Farrell et al.
ELIFE (2016)
Cyclooxygenase-1 as a Potential Therapeutic Target for Seizure Suppression: Evidences from Zebrafish Pentylenetetrazole-Seizure Model
Patrcia Goncalves Barbalho et al.
FRONTIERS IN NEUROLOGY (2016)
Clinical characteristics of patients with benign nonlesional temporal lobe epilepsy
Jiyeon Kim et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2016)
Hippocampal neuronal cyclooxygenase-2 downstream signaling imbalance in a rat model of chronic aluminium gluconate administration
Hong Wang et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2015)
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats
Rita Citraro et al.
BRAIN RESEARCH BULLETIN (2015)
Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment
Jatinder Katyal et al.
EPILEPSY & BEHAVIOR (2015)
Animal models in epilepsy research: legacies and new directions
Brian P. Grone et al.
NATURE NEUROSCIENCE (2015)
Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus
Jianxiong Jiang et al.
NEUROBIOLOGY OF DISEASE (2015)
A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice
Borna Payandemehr et al.
NEUROCHEMICAL RESEARCH (2015)
Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus
Ying-Hao Ho et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Lipopolysaccharide induced increase in seizure activity in two animal models of absence epilepsy WAG/Rij and GAERS rats and Long Evans rats
Zsolt Kovacs et al.
BRAIN RESEARCH BULLETIN (2014)
Role of Inflammatory Mediators in the Pathogenesis of Epilepsy
Tadayuki Shimada et al.
MEDIATORS OF INFLAMMATION (2014)
The Potential of Antiseizure Drugs and Agents that Act on Novel Molecular Targets as Antiepileptogenic Treatments
Rafal M. Kaminski et al.
NEUROTHERAPEUTICS (2014)
Epilepsy and Inflammation in the Brain: Overview and Pathophysiology
Annamaria Vezzani
EPILEPSY CURRENTS (2014)
Animal models of epilepsy: use and limitations
Ludmyla Kandratavicius et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Seizure susceptibility in immature brain due to lack of COX-2-induced PGF2α
Jee-In Chung et al.
EXPERIMENTAL NEUROLOGY (2013)
Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain
Young Se Kwon et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Tenidap, an agonist of the inwardly rectifying K+ channel Kir2.3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy
Lan Xu et al.
NEUROLOGICAL RESEARCH (2013)
Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats
Lei Ma et al.
BRAIN RESEARCH (2012)
Stress and expression of cyclooxygenases (cox1, cox2a, cox2b) and intestinal eicosanoids, in Atlantic salmon, Salmo salar L.
R. E. Olsen et al.
FISH PHYSIOLOGY AND BIOCHEMISTRY (2012)
Up-regulation of major vault protein in the frontal cortex of patients with intractable frontal lobe epilepsy
Bei Liu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy
J. Schlichtiger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Rethinking the role of cyclooxygenase-1 in neuroinflammation More than homeostasis
Francesca Bosetti et al.
CELL CYCLE (2010)
Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy
Linda Holtman et al.
EPILEPSY RESEARCH (2010)
The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy
Nadine Polascheck et al.
EXPERIMENTAL NEUROLOGY (2010)
Neuroprotective Effect of Visnagin on Kainic Acid-induced Neuronal Cell Death in the Mice Hippocampus
Min-Soo Kwon et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2010)
COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats
Erwin A. van Vliet et al.
NEUROPHARMACOLOGY (2010)
Can Animal Models of Disease Reliably Inform Human Studies?
H. Bart van der Worp et al.
PLOS MEDICINE (2010)
Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy
L. Holtman et al.
EPILEPSY RESEARCH (2009)
Cyclooxygenase in normal human tissues - is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?
Nina Zidar et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin
Maria Grazia Rimoli et al.
NEUROPHARMACOLOGY (2009)
Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition
Guido Zibell et al.
NEUROPHARMACOLOGY (2009)
Stage- and region-specific cyclooxygenase expression and effects of a selective COX-1 inhibitor in the mouse amygdala kindling model
Shinji Tanaka et al.
NEUROSCIENCE RESEARCH (2009)
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients
Kirstin Stricker et al.
BMC MUSCULOSKELETAL DISORDERS (2008)
Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice
Ashish Dhir et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2007)
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies
C. O. Bingham et al.
RHEUMATOLOGY (2007)
Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action
Ashish Dhir et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus
Keun-Hwa Jung et al.
NEUROBIOLOGY OF DISEASE (2006)
Brain uptake of nonsteroidal anti-inflammatory drugs: Ibuprofen, flurbiprofen, and indomethacin
Jagan Mohan R. Parepally et al.
PHARMACEUTICAL RESEARCH (2006)
Effect of rofecoxib, a cyclo-oxygenase-2 inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol-induced chemical kindling in mice
A Dhir et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice
A Dhir et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2005)
Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis
T Kuwano et al.
FASEB JOURNAL (2004)
Cyclooxygenase enzymes: Regulation and function
FA Fitzpatrick
CURRENT PHARMACEUTICAL DESIGN (2004)
Hippocampal kindling epilepto,genesis upregulates neuronal cyclooxygenase-2 expression in neocortex
B Tu et al.
EXPERIMENTAL NEUROLOGY (2003)
Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure
K Okada et al.
BRAIN RESEARCH (2001)
The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus
T Kunz et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Cyclooxygenases in the central nervous system: Implications for treatment of neurological disorders
A Yermakova et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
Mechanism of action of acetaminophen: Is there a cyclooxygenase 3?
RM Botting
CLINICAL INFECTIOUS DISEASES (2000)
Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury
PK Dash et al.
JOURNAL OF NEUROTRAUMA (2000)
Share Paper
